Navigating the nuances of the Canadian guideline's stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders

CMAJ. 2024 Mar 17;196(10):E348. doi: 10.1503/cmaj.150034-l.NO ABSTRACTPMID:38499309 | PMC:PMC10948185 | DOI:10.1503/cmaj.150034-l

Source: cmaj - March 18, 2024 Category: General Medicine Authors: Raymond Julius O Elefante Clara Lu Paxton J Bach Source Type: research